Hims & Hers Health launches injectable and oral testosterone therapies

The treatments are for eligible men with low testosterone and are offered with licensed providers through Hims.

GetSignal Hims & Hers Health, Inc. HIMS

Hims & Hers Health announced on October 21, 2026, the launch of new injectable and oral testosterone replacement therapies (TRT) for eligible men. The company said the launch expands its men's health program.

Key facts

Announced
October 21, 2026
Products
Injectable and oral testosterone replacement therapies (TRT)
Eligibility
Eligible men

All HIMS news

Source: The company's release on Business Wire, October 21, 2026.

Written by GetSignal with AI from the company's press release.

Not investment advice.

Follow Hims & Hers Health on GetSignal

Its filings, insider trades and company news in one feed. Free on iPhone and Android.

Download on the App Store Get it on Google Play